切换至 "中华医学电子期刊资源库"

中华心脏与心律电子杂志 ›› 2026, Vol. 14 ›› Issue (01) : 1 -10. doi: 10.3877/cma.j.issn.2095-6568.2026.01.001

标准与规范

心血管植入型电子器械磁共振成像检查标准流程建议
中华医学会心电生理和起搏分会, 中国医学装备协会心律失常技术分会, 中国医师协会心律学专业委员会   
  • 收稿日期:2025-12-24 出版日期:2026-03-25

Recommended standardized protocol for magnetic resonance imaging in patients with cardiovascular implantable electronic devices

Chinese Society of Pacing and Electrophysiology, The Arrhythmia Technology Society of China Association of Medical Equipment, Chinese Society of Arrhythmias   

  • Received:2025-12-24 Published:2026-03-25
引用本文:

中华医学会心电生理和起搏分会, 中国医学装备协会心律失常技术分会, 中国医师协会心律学专业委员会. 心血管植入型电子器械磁共振成像检查标准流程建议[J/OL]. 中华心脏与心律电子杂志, 2026, 14(01): 1-10.

Chinese Society of Pacing and Electrophysiology, The Arrhythmia Technology Society of China Association of Medical Equipment, Chinese Society of Arrhythmias. Recommended standardized protocol for magnetic resonance imaging in patients with cardiovascular implantable electronic devices[J/OL]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2026, 14(01): 1-10.

磁共振(MR)成像是重要的无创影像检查方法。心血管植入型电子器械(CIED)患者接受MR检查既往被视为禁忌,但随着设备技术革新,在遵循特定流程前提下,绝大多数CIED患者已可安全接受MR检查。为规范国内临床操作,中华医学会心电生理和起搏分会、中国医学装备协会心律失常技术分会和中国医师协会心律学专业委员会组织国内相关领域专家制订本标准流程建议。本建议明确了关键术语定义,围绕植入MR兼容与非兼容CIED患者,系统梳理了检查前、中、后全流程关键节点,共形成15条推荐意见,并针对特殊临床情况给出分层管理策略,旨在为临床提供标准化操作参考,提升CIED患者行MR检查的安全性与可及性。

Magnetic resonance (MR) imaging represents a cornerstone of non-invasive diagnostic radiology. Historically, patients with cardiovascular implantable electronic devices (CIED) were universally excluded from MR procedures due to safety concerns. However, iterative innovations in device technology have shifted this paradigm, enabling the majority of CIED recipients to undergo MR imaging safely when stringent protocols are implemented. To address the growing clinical demand and standardize practice in China, a multidisciplinary panel of experts convened by the Chinese Society of Pacing and Electrophysiology (CSPE), The Arrhythmia Technology Society of China Association of Medical Equipment(CAME) , and Chinese Medical Doctor Association Cardiac Rhythm Management Committee developed this consensus guideline. This document defines key terminology and establishes a comprehensive framework encompassing pre-procedural patient selection, intra-procedural monitoring protocols, and post-procedural follow-up for both MR-conditional and legacy non-MR-conditional CIED. Fifteen evidence-based recommendations are presented alongside risk-stratified management algorithms for complex clinical scenarios. The guideline aims to standardize clinical decision-making and mitigate procedural risks, ultimately expanding access to MR imaging for eligible CIED patients.

图1 心血管植入型电子器械患者磁共振检查流程注:MR为磁共振,CIED为心血管植入型电子器械,ICD为植入型心律转复除颤器
表1 心血管植入型电子器械(CIED)患者磁共振(MR)检查相关人员组成及其职责
人员 职责
患者

确保接诊医护和放射科操作人员均明确患者体内存在CIED,并已完成相应风险评估

扫描前向临床科室、放射科提供CIED信息

心内科医师/起搏电生理医师/CIED工程师

确保尽可能植入MR兼容的CIED系统

植入前签署知情同意时告知MR兼容相关问题

植入后对患者进行MR相关教育,并明确MR检查遇到困难时应联系的人员或机构

在医疗记录和CIED识别卡中注明CIED系统及其各组件的MR兼容性

MR检查预约过程中,如有需要,应与放射科操作人员沟通CIED详细信息、MR标识及潜在的禁 忌情况(例如废弃导线)

MR检查前和MR检查后均进行设备询问,确认患者起搏依赖性、设备MR兼容性及程控

提出MR检查需求的临床科室医师

基于普通患者的考虑因素决定CIED患者是否需要MR检查

在检查单中注明患者是否植入CIED

提供MR检查临床适应证,以便制订适当的检查方案

与心内科和患者沟通协调,为放射科提供CIED相关信息及风险评估情况

确认患者既往病史,了解近期有无恶性心律失常发作等

放射科医师

建立MR转诊接收流程,并明确负责资料审核与制订扫描方案的放射科医师

审核转诊信息,并根据MR兼容条件制订扫描方案

避免患者在MR检查过程中出现CIDE相关风险

放射科技师

确保每例患者都遵循所有所在医疗机构的MR检查流程

严格遵守放射科医师制订的MR扫描条件

负责患者在MR检查前、检查中和检查后的安全与沟通

确保扫描完整,不需要召回,或在必要时寻求建议

负责扫描期间的节律监测(取决于所在医疗机构的要求)

图2 不同制造商针对心血管植入型电子器械的磁共振扫描流程优化的特殊功能MR或MRI为磁共振,ICD为植入型心律转复除颤器;CRT-D为心脏再同步治疗除颤器
[1]
Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy[J]. Eur Heart J, 2021, 42(35):3427-3520.
[2]
Indik JH, Gimbel JR, Abe H, et al. 2017 HRS Expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices[J]. Heart Rhythm, 2017, 14(7):e97-e153.
[3]
Stühlinger M, Burri H, Vernooy K, et al. EHRA Consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices[J]. Europace, 2022, 24(9):1512-1537.
[4]
褚松筠, 王玉玲, 蒋捷, 等. 起搏器患者进行磁共振检查的安全性研究[J].临床心血管病杂志, 2020, 36(11):1008-1012.
[5]
邢强, 祖克拉·吐尔洪, 张疆华, 等. 磁共振兼容起搏器行1.5 T磁共振扫描的安全性研究[J].中华心律失常学杂志,2021, 25(5):408-412.
[6]
武敏, 于海波, 梁延春, 等. 心脏起搏器植入患者进行核磁共振扫描安全性研究[J].临床军医杂志,2019, 47(2):153-155.
[7]
Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T[J]. Circulation, 2004, 110(5):475-482.
[8]
Nazarian S, Hansford R, Rahsepar AA, et al. Safety of magnetic resonance imaging in patients with cardiac devices[J]. N Engl J Med, 2017, 377(26):2555-2564.
[9]
Russo RJ, Costa HS, Silva PD, et al. Assessing the risks associated with mri in patients with a pacemaker or defibrillator[J]. N Engl J Med, 2017, 376(8):755-764.
[10]
Balmer C, Gass M, Dave H, et al. Magnetic resonance imaging of patients with epicardial leads: in vitro evaluation of temperature changes at the lead tip[J]. J Interv Card Electrophysiol, 2019, 56(3):321-326.
[11]
Mattei E, Gentili G, Censi F, et al. Impact of capped and uncapped abandoned leads on the heating of an MR-conditional pacemaker implant[J]. Magn Reson Med, 2015, 73(1):390-400.
[12]
Bhuva AN, Moralee R, Brunker T, et al. Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices[J]. Eur Heart J, 2022, 43(26):2469-2478.
[13]
Schaller RD, Brunker T, Riley MP, et al. Magnetic resonance imaging in patients with cardiac implantable electronic devices with abandoned leads[J]. JAMA Cardiol, 2021, 6(5):549-556.
[14]
Greenhill MJ, Rangan P, Su W, et al. MRI in Patients with cardiovascular implantable electronic devices and fractured or abandoned leads[J]. Radiol Cardiothorac Imaging, 2024, 6(3):e230303.
[15]
Homsi R, Mellert F, Luechinger R, et al. Safety and feasibility of magnetic resonance imaging of the brain at 1.5 Tesla in patients with temporary transmyocardial pacing leads[J]. Thorac Cardiovasc Surg, 2019, 67(2):86-91.
[16]
Rahsepar AA, Zimmerman SL, Hansford R, et al. The relationship between mri radiofrequency energy and function of nonconditional implanted cardiac devices: a prospective evaluation[J]. Radiology, 2020, 295(2):307-313.
[17]
Mollerus M, Albin G, Lipinski M, et al. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions[J]. Europace, 2010, 12(7):947-951.
[18]
Golestanirad L, Rahsepar AA, Kirsch JE, et al. Changes in the specific absorption rate (SAR) of radiofrequency energy in patients with retained cardiac leads during MRI at 1.5T and 3T[J]. Magn Reson Med, 2019, 81(1):653-669.
[19]
Bhuva A, Charles-Edwards G, Ashmore J, et al. Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices[J]. Heart, 2024, 110(4):e3.
[20]
Munawar DA, Chan J, Emami M, et al. Magnetic resonance imaging in non-conditional pacemakers and implantable cardioverter-defibrillators: a systematic review and meta-analysis[J]. Europace, 2020, 22(2):288-298.
[21]
Shah AD, Morris MA, Hirsh DS, et al. Magnetic resonance imaging safety in nonconditional pacemaker and defibrillator recipients: a meta-analysis and systematic review[J]. Heart Rhythm, 2018, 15(7):1001-1008.
[22]
Kim D, Collins JD, White JA, et al. SCMR Expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device[J]. J Cardiovasc Magn Reson, 2024, 26(1):100995.
[23]
Vuorinen AM, Lehmonen L, Karvonen J, et al. Reducing cardiac implantable electronic device-induced artefacts in cardiac magnetic resonance imaging[J]. Eur Radiol, 2023, 33(2):1229-1242.
[24]
Schwitter J, Gold MR, Al Fagih A, et al. Image quality of cardiac magnetic resonance imaging in patients with an implantable cardioverter defibrillator system designed for the magnetic resonance imaging environment[J]. Circ Cardiovasc Imaging, 2016, 9(5):e004025.
[25]
Do DH, Eyvazian V, Bayoneta AJ, et al. Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices[J]. Heart Rhythm, 2018, 15(2):218-225.
[26]
Gimbel JR, Bello D, Schmitt M, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla[J]. Heart Rhythm, 2013, 10(5):685-691.
[27]
Shenthar J, Milasinovic G, Al Fagih A, et al. MRI Scanning in patients with new and existing CapSureFix Novus 5076 pacemaker leads: randomized trial results[J]. Heart Rhythm, 2015, 12(4):759-765.
[28]
Awad K, Griffin J, Crawford TC, et al. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions[J]. Heart Rhythm, 2015, 12(10):2155-2161.
[29]
Ching CK, Chakraborty RN, Kler TS, et al. Clinical safety and performance of a MRI conditional pacing system in patients undergoing cardiac MRI[J]. Pacing Clin Electrophysiol, 2017, 40(12):1389-1395.
[30]
Friedman HL, Acker N, Dalzell C, et al. Magnetic resonance imaging in patients with recently implanted pacemakers[J]. Pacing Clin Electrophysiol, 2013, 36(9):1090-1095.
[31]
Barreiro-Pérez M, Cabeza B, Calvo D, et al. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document[J]. Rev Esp Cardiol (Engl Ed), 2023, 76(3):183-196.
[32]
Marczak M, Świerżyńska E, Śpiewak M, et al. Magnetic resonance imaging in patients with implanted cardiac electrotherapy devices: a statement from experts of the Polish Medical Society of Radiology, the Polish Society of Cardiology, and the Polish Society of Electroradiology[J]. Pol J Radiol, 2024, 89:e1-e5.
[33]
Minaskeian N, Hajnal SP, Liu MB, et al. Safety of magnetic resonance imaging in patients with cardiac implantable electronic devices with generator and lead(s) brand mismatch[J]. J Appl Clin Med Phys, 2022, 23(3):e13520.
[34]
Pitman BM, Ariyaratnam J, Williams K, et al. The burden of cardiac implantable electronic device checks in the peri-MRI setting: the CHECK-MRI study[J]. Heart Lung Circ, 2023, 32(2):252-260.
[35]
Cronin EM, Wilkoff BL. Magnetic resonance imaging conditional pacemakers: rationale, development and future directions[J]. Indian Pacing Electrophysiol J, 2012, 12(5):204-212.
[36]
Mullane S, Michaelis K, Henrikson C, et al. Utilization and programming of an automatic MRI recognition feature for cardiac rhythm management devices[J]. Heart Rhythm O2, 2021, 2(2):132-137.
[37]
Savouré A, Mechulan A, Burban M, et al. The Kora pacemaker is safe and effective for magnetic resonance imaging[J]. Clin Med Insights Cardiol, 2015, 9:85-90.
[38]
Thiyagarajah A, Strik M, Ploux S, et al. Contemporary management and programming of cardiac implantable electronic devices in patients undergoing magnetic resonance imaging[J]. Heart Rhythm, 2025: S1547-5271(25)03148-0.
[39]
Baroni M, Carbonaro M, Felisi M, et al. Simplifying MRI workflow for patients with cardiac implantable electronic devices: Technologies for automatic MRI mode switching[J]. Int J Cardiol, 2026, 444:134006.
[40]
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会. 心血管植入型电子器械术后随访的专家共识(2020)[J].中华心律失常学杂志,2020, 24(6):532-544.
[1] 中国临床肿瘤学会乳腺癌专家委员会, 中国医师协会肿瘤多学科诊疗专业委员会, 广东省药学会. 乳腺癌内分泌治疗超说明书用药专家共识[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(02): 69-81.
[2] 中华医学会超声医学分会, 中国研究型医院肿瘤介入治疗委员会, 中国妇幼保健协会乳腺保健专业委员会, 中华医学会肿瘤学分会乳腺癌专业委员会, 中国抗癌协会乳腺癌专业委员会, 中国人体健康科技促进会乳腺专业委员会. 无手术适应证乳腺癌消融治疗专家共识(2025版)[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(01): 1-8.
[3] 泌尿功能障碍预防和治疗专家组. 尿液菌群移植在部分女性泌尿系统疾病中的应用规范专家共识[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(02): 127-133.
[4] 中国研究型医院学会微创外科学专业委员会. 胆道残余结石诊疗中国专家共识(2026版)[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(01): 1-8.
[5] 戴宗伯, 张城硕, 郭庭维, 何知远, 赵昊宇, 张宇慈, 张佳林. 基于MRI影像组学机器学习构建肝细胞癌微血管侵犯预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 36-44.
[6] 刘郁芳, 赵青. 直肠癌MRI影像学评估:从精准分期到预后预测的研究进展与展望[J/OL]. 中华结直肠疾病电子杂志, 2026, 15(01): 31-36.
[7] 汤为, 文海涛, 屈耀铭, 马安东, 黄成燕, 芮琦虹, 蒋春秀, 王显龙. 脑实质内表皮样囊肿影像特征及误判分析[J/OL]. 中华神经创伤外科电子杂志, 2026, 12(01): 39-44.
[8] 脊髓电刺激治疗卒中后偏瘫中国专家共识编写组, 中华医学会神经外科学分会功能神经外科学组, 中国研究型医院学会神经外科学专业委员会, 世界华人神经外科协会功能神经外科专业委员会, 北京医学会神经外科学分会功能神经外科专业组, 北京医学会神经外科学分会周围神经外科专业组. 脊髓电刺激治疗卒中后偏瘫中国专家共识(2025年)[J/OL]. 中华脑科疾病与康复杂志(电子版), 2026, 16(01): 8-18.
[9] 高增霞, 贺云飞, 赵娜. DCE-MRI联合Gd-EOB-DTPA MRI纹理特征对肝细胞癌经导管动脉化疗栓塞术后疗效的评估[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(02): 108-113.
[10] 常莉娜, 刘囡囡. DWI联合DCE-MRI定量参数对局部进展期直肠癌新辅助治疗后病理完全缓解的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(02): 125-129.
[11] 孙钢. 零液氦磁共振成像系统的发展现状和展望[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(01): 1-5.
[12] 魏晓雅, 王旭, 蒋馨源, 杨娜娜, 王泽一, 屠建锋, 刘存志. 针刺治疗原发性高血压的磁共振成像临床研究进展[J/OL]. 中华针灸电子杂志, 2026, 15(01): 43-46.
[13] 中国医师协会介入医师分会外周血管专家工作委员会. 支气管动脉栓塞治疗咯血护理规范专家共识[J/OL]. 中华介入放射学电子杂志, 2026, 14(01): 1-11.
[14] 林净净, 韩佳育, 成官迅, 李世峰. 基于ABIDE数据库的孤独症谱系障碍小脑形态自动分割与多中心验证[J/OL]. 中华诊断学电子杂志, 2026, 14(01): 24-30.
[15] 汪艺宸, 陈涛, 周嘉璇, 李新春, 万齐. 中国肺癌磁共振成像从功能性成像到影像组学的诊断演进[J/OL]. 中华诊断学电子杂志, 2026, 14(01): 38-43.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?